Diltiazem

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Diltiazem and local guidelines before prescribing.

Calcium channel blocker (non-dihydropyridine)

Mechanism

Non-dihydropyridine calcium channel blocker with negative chronotropic and inotropic effects.

Uses

Angina, hypertension, AF and SVT rate control.

Dosing

4 more dose entries from the chapters

Side effects

Bradycardia, ankle oedema, headache, constipation, heart block.

Interactions

Beta-blockers risk bradycardia and block; raises levels of statins, ciclosporin, carbamazepine; avoid with ivabradine.

Contraindications and cautions

Heart block, severe bradycardia, left ventricular failure with pulmonary congestion

Monitoring

ECG, pulse, BP

Pregnancy and breastfeeding

Avoid unless essential

Renal and hepatic impairment

Reduce dose in renal and hepatic impairment

Overdose and reversal

Calcium, atropine, pacing

Special advice

Avoid in reduced EF heart failure and with beta-blockers if conduction disease.

More from the textbook: uses, cautions and other points
Where it is discussed in the book